Most importantly, the team developed a fundamentally new system in need of blockchain technology. For example, several ICO in Biomedicine (ARNA Genomics and doc.ai NRN) suggest to use a blockchain for validation, and thus funding projects before market entry. This approach destroys the monopoly regulators and the giants of the pharma. In the medium term such projects will allow the explosive growth of the investment.